Rivaroxaban 15 MG Oral Tablet [Xarelto] Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Xarelto

Pipeline

Phase 3: 1

Top Sponsors

Ottawa Heart Institute Research Corporation1

Indications

Radial Artery Occlusion1
Heart Disease1

Rochester, Minnesota1 trial

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

Mayo Clinic

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.